Latest Intraop Medical Corp (IOPDQ) Headlines
Post# of 3
Posted On: 03/10/2014 6:49:33 AM
Latest Intraop Medical Corp (IOPDQ) Headlines
Firsthand Technology Value Fund Discloses Top Portfolio Holdings
GlobeNewswire - Mon Feb 10, 8:00AM CST
Firsthand Technology Value Fund, Inc. (Nasdaq:SVVC) (the "Fund"), a publicly-traded venture capital fund that invests in technology and cleantech companies, disclosed today that its top five holdings as of January 31, 2014 were Twitter, Facebook, IntraOp Medical, Turn, and AliphCom.
Firsthand Technology Value Fund Discloses Preliminary NAV of $28.31 Per Share as of December 31, 2013
GlobeNewswire - Thu Jan 16, 8:00AM CST
Firsthand Technology Value Fund, Inc. (Nasdaq:SVVC) (the "Fund"), a publicly-traded venture capital fund that invests in technology and cleantech companies, today disclosed its preliminary net asset value (NAV) of $28.31 per share, as of December 31, 2013. The Fund's estimated total return for 2013, based on the December 31, 2013 preliminary NAV, was 25.3%.* The Fund's total return for the year, based on the market price of its stock, was 34.6%.*
New Studies of Electron Beam Radiation Treatment Show Women Can Get a One Day Treatment for Their Breast Cancer and Nearly All Breast Cancer Patients Can Benefit
Business Wire - Thu Dec 12, 2:44PM CST
The recent release of comprehensive, multi-year studies of thousands of cancer patients out of Europe demonstrate clearly the substantial advantages for the use of intraoperative electron-beam radiation therapy techniques in providing significantly improved clinical outcomes and psychological benefits to breast cancer patients. Most experts agree that intraoperative electron radiation treatment (IOERT) is beneficial in the treatment of many locally advanced and recurrent cancers. These studies are the first to clearly demonstrate that IOERT will also have a major role in the treatment of breast cancer. www.intraopmedical.com.
Firsthand Technology Value Fund Discloses Top Holdings
GlobeNewswire - Fri Dec 06, 11:45AM CST
Firsthand Technology Value Fund, Inc. (Nasdaq:SVVC) (the "Fund"), a publicly-traded venture capital fund that invests in technology and cleantech companies, disclosed today that its top five holdings as of November 30, 2013 were Twitter, Facebook, IntraOp Medical, AliphCom, and Sunrun.
IntraOp Medical Completes Restructuring
Marketwire - Mon Oct 07, 12:46PM CDT
IntraOp Medical Corporation, a leading provider of innovative technology-based cancer treatments, today announced the completion of its sale to an investment group led by Firsthand Technology Value Fund. Inc. (NASDAQ: SVVC), a publicly traded venture capital fund.
Firsthand Technology Value Fund Completes Purchase of IntraOp Medical Corporation
GlobeNewswire - Mon Oct 07, 12:09PM CDT
Firsthand Technology Value Fund, Inc. (Nasdaq:SVVC) ("Firsthand" or the "Fund"), a publicly-traded venture capital fund that invests in technology and cleantech companies, announced today that it has completed its purchase of a majority interest in IntraOp Medical Corporation ("IntraOp").
Firsthand Technology Value Fund Discloses Top Portfolio Holdings
GlobeNewswire - Mon Feb 10, 8:00AM CST
Firsthand Technology Value Fund, Inc. (Nasdaq:SVVC) (the "Fund"), a publicly-traded venture capital fund that invests in technology and cleantech companies, disclosed today that its top five holdings as of January 31, 2014 were Twitter, Facebook, IntraOp Medical, Turn, and AliphCom.
Firsthand Technology Value Fund Discloses Preliminary NAV of $28.31 Per Share as of December 31, 2013
GlobeNewswire - Thu Jan 16, 8:00AM CST
Firsthand Technology Value Fund, Inc. (Nasdaq:SVVC) (the "Fund"), a publicly-traded venture capital fund that invests in technology and cleantech companies, today disclosed its preliminary net asset value (NAV) of $28.31 per share, as of December 31, 2013. The Fund's estimated total return for 2013, based on the December 31, 2013 preliminary NAV, was 25.3%.* The Fund's total return for the year, based on the market price of its stock, was 34.6%.*
New Studies of Electron Beam Radiation Treatment Show Women Can Get a One Day Treatment for Their Breast Cancer and Nearly All Breast Cancer Patients Can Benefit
Business Wire - Thu Dec 12, 2:44PM CST
The recent release of comprehensive, multi-year studies of thousands of cancer patients out of Europe demonstrate clearly the substantial advantages for the use of intraoperative electron-beam radiation therapy techniques in providing significantly improved clinical outcomes and psychological benefits to breast cancer patients. Most experts agree that intraoperative electron radiation treatment (IOERT) is beneficial in the treatment of many locally advanced and recurrent cancers. These studies are the first to clearly demonstrate that IOERT will also have a major role in the treatment of breast cancer. www.intraopmedical.com.
Firsthand Technology Value Fund Discloses Top Holdings
GlobeNewswire - Fri Dec 06, 11:45AM CST
Firsthand Technology Value Fund, Inc. (Nasdaq:SVVC) (the "Fund"), a publicly-traded venture capital fund that invests in technology and cleantech companies, disclosed today that its top five holdings as of November 30, 2013 were Twitter, Facebook, IntraOp Medical, AliphCom, and Sunrun.
IntraOp Medical Completes Restructuring
Marketwire - Mon Oct 07, 12:46PM CDT
IntraOp Medical Corporation, a leading provider of innovative technology-based cancer treatments, today announced the completion of its sale to an investment group led by Firsthand Technology Value Fund. Inc. (NASDAQ: SVVC), a publicly traded venture capital fund.
Firsthand Technology Value Fund Completes Purchase of IntraOp Medical Corporation
GlobeNewswire - Mon Oct 07, 12:09PM CDT
Firsthand Technology Value Fund, Inc. (Nasdaq:SVVC) ("Firsthand" or the "Fund"), a publicly-traded venture capital fund that invests in technology and cleantech companies, announced today that it has completed its purchase of a majority interest in IntraOp Medical Corporation ("IntraOp").
(0)
(0)Intraop Medical Corp (IOPDQ) Stock Research Links
Scroll down for more posts ▼